Standigm and Nashville Biosciences join to revolutionize early drug discovery
Companies will identify novel therapeutic targets using Standigm’s explainable AI and Nashville Biosciences’ datasets SEOUL, South Korea, Aug. 10, 2023 /PRNewswire/ — Standigm, a company using artificial intelligence (AI) technology for drug discovery...